Monoclonal antibodies are designed to recognize and attach to specific proteins on the surface of cells. Each monoclonal antibody recognizes one particular protein. They work in different ways depending on the protein they are targeting. So different monoclonal antibodies have to be made to target different types of cancer. OMICS Group International is one of the leading Open Access Publishers which is running 700+ peer-reviewed journals. OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. It follows an Open Access publication model that enables the dissemination of research articles to the global community free of cost. Journal of Glycobiology is one of the best open access, globally maiden journal with the wide range of area that deals with Cancer Glycobiology, Glycopeptides, drug discovery and Glycomics, Fucanomes and Galactanomes, Structural Glycobiology, Membrane glycoproteins, Protein De glycosylation and carbohydrate diet and to introduce various forms of technological developments. Journal of Glycobiology is among the top Open Access journals which publish the articles related to Monoclonal antibodies . Journal of Glycobiology provide a forum for Scientists from all over the world to exchange ideas, to propagate the advancement of science.
Last date updated on May, 2021